Cystatin C: An Emerging Biomarker in Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|13|2|164-179

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.2, 2013-01, pp. : 164-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 2, 2013-01 ,pp. : 180-200

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Role of the Urotensin II System in Cardiovascular Disease

By  

Heart Drug, Vol. 3, Iss. 3, 2003-11 ,pp. : 153-158

Karger

Access to resources Recommend Favorite

A New Emerging Risk Factor for Cardiovascular Disease: Apo(a) Polymorphism

By  

Heart Drug, Vol. 3, Iss. 3, 2003-11 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Systems Biology Research into Cardiovascular Disease: Contributions of Lipidomics-based Approaches to Biomarker Discovery

By  

Current Drug Discovery Technologies, Vol. 12, Iss. 3, 2015-01 ,pp. : 129-154

Bentham Science Publishers

Access to resources Recommend Favorite

Copeptin as a Biomarker in Cardiac Disease

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 2, 2013-01 ,pp. : 231-240

Bentham Science Publishers

Access to resources Recommend Favorite